FOXM1 and cancer: To ascertain these hypotheses, further experiments are needed to determine whether sustained O-GlcNAcylation of GSK-3β could be involved in the increase of cyclin D1 stability in MCF7 and HCT116 cancer cells, as shown for FoxM1 in gastric cancer cells (48).